CNS – Dividend Returns, History & Calculator
Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fix
...Company Info
Price Data
Dividend Data
Growth Rates
Total Returns
Fair Value
Financial Metrics
Calculate your CNS Dividend Returns
Quickly and easily calculate CNS dividend yield using our CNS calculator. Adjust the fields below to see how your CNS investments snowball over time.
Portfolio Growth Over Time
Data last updated: October 17, 2025 1:42 am
Year-by-Year Portfolio Growth (Realistic DRIP Scenario)
Year | Start Balance | Start Shares | Share Price | Dividend / Share | Dividend Yield | Yield on Cost | Annual Dividend | Total Dividends | End Shares | End Balance |
---|---|---|---|---|---|---|---|---|---|---|
1 | $10,000 | 152 | $65.80 | $0.62 | 3.77% | 3.77% | $411 | $411 | 176 | $11,611 |
2 | $12,624 | 176 | $71.54 | $0.61 | 3.40% | 3.70% | $461 | $871 | 200 | $14,285 |
3 | $15,532 | 200 | $77.79 | $0.60 | 3.07% | 3.63% | $505 | $1,377 | 222 | $17,238 |
4 | $18,742 | 222 | $84.58 | $0.59 | 2.77% | 3.56% | $545 | $1,922 | 242 | $20,488 |
5 | $22,276 | 242 | $91.97 | $0.57 | 2.50% | 3.49% | $581 | $2,503 | 262 | $24,057 |
6 | $26,157 | 262 | $99.99 | $0.56 | 2.25% | 3.43% | $612 | $3,115 | 280 | $27,969 |
7 | $30,411 | 280 | $108.72 | $0.55 | 2.03% | 3.36% | $639 | $3,754 | 297 | $32,250 |
8 | $35,065 | 297 | $118.22 | $0.54 | 1.84% | 3.30% | $662 | $4,416 | 312 | $36,928 |
9 | $40,151 | 312 | $128.54 | $0.53 | 1.66% | 3.24% | $682 | $5,098 | 327 | $42,033 |
10 | $45,703 | 327 | $139.76 | $0.52 | 1.50% | 3.18% | $698 | $5,796 | 341 | $47,601 |
CNS Dividend History
Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
---|---|---|---|---|---|
08/11/2025 | 08/11/2025 | $0.620 | 3.34% | 3.38% | $73.35 |
05/12/2025 | 05/12/2025 | $0.620 | 2.92% | 2.99% | $82.87 |
03/03/2025 | 03/03/2025 | $0.620 | 2.79% | 2.90% | $85.60 |
11/18/2024 | 11/18/2024 | $0.590 | 2.36% | 2.36% | $99.89 |
08/12/2024 | 08/12/2024 | $0.590 | 2.85% | 2.88% | $82.02 |
05/10/2024 | 05/10/2024 | $0.590 | 3.28% | 3.34% | $70.72 |
03/01/2024 | 03/01/2024 | $0.590 | 3.15% | 3.23% | $73.05 |
11/10/2023 | 11/10/2023 | $0.570 | 4.32% | 4.32% | $52.82 |
08/11/2023 | 08/11/2023 | $0.570 | 3.43% | 3.46% | $65.98 |
05/12/2023 | 05/12/2023 | $0.570 | 4.13% | 4.20% | $54.30 |
03/03/2023 | 03/03/2023 | $0.570 | 3.10% | 3.18% | $71.69 |
11/10/2022 | 11/10/2022 | $0.550 | 3.41% | 3.41% | $64.45 |
08/12/2022 | 08/12/2022 | $0.550 | 4.31% | 2.83% | $77.66 |
05/13/2022 | 05/13/2022 | $0.550 | 4.46% | 3.02% | $72.87 |
03/04/2022 | 03/04/2022 | $0.550 | 4.04% | 2.82% | $78.01 |
11/12/2021 | 11/12/2021 | $1.70 | 3.06% | 6.82% | $99.75 |
08/13/2021 | 08/13/2021 | $0.450 | 3.11% | 2.04% | $88.17 |
05/14/2021 | 05/14/2021 | $0.450 | 3.67% | 2.46% | $73.08 |
03/05/2021 | 03/05/2021 | $0.450 | 3.98% | 2.73% | $65.89 |
11/13/2020 | 11/13/2020 | $1.39 | 4.02% | 8.74% | $63.61 |
CNS 10-yr Total Return ($10,000 invested)
This analysis of CNS demonstrates the power of dividend reinvestment over a 10-year period with a $10,000 initial investment. The dividend reinvestment strategy delivered a 14.7% CAGR, representing strong long-term performance. While recent 5-year returns averaged 7.3% annually, the exceptional 10-year performance of 14.7% demonstrates sustained long-term growth. Dividend payments have grown from $0.6200 to $0.7500 per share, reflecting the 9.5% annual dividend growth rate. The DRIP strategy provided 19% more total return compared to collecting dividends as cash, highlighting the compounding effect of reinvestment.
Total Return with and without DRIP (CNS)
Over the selected period, investing $10,000 in CNS would grow to $67,282 with DRIP (572.8%), and $50,397 without DRIP (404.0%).
CNS Dividend Reinvestment Snowball
Investing $10,000 + $100/mo in CNS with historic price growth (8.75%) and dividend growth (-1.89%) produces dramatically different outcomes depending on whether you reinvest dividends.
After 20 Years
Your Investment: $34,000
Portfolio: $146,949
Annual Dividend: $705
Yield on Cost: 2.07%
Total Dividends: $12,815
Portfolio: $126,885
Total Dividends: $10,810
After 30 Years
Your Investment: $46,000
Portfolio: $369,636
Annual Dividend: $634
Yield on Cost: 1.38%
Total Dividends: $19,613
Portfolio: $303,630
Total Dividends: $16,134
Milestones on the way
By year 13, the compounding really starts to show. Your total dividends collected reach $7,789 against a total investment of $25,600. At this point, your portfolio is throwing off $705 per year in dividends alone.
By year 17, the annual dividend climbs to around your initial contribution. For a starting investment of $10,000, the yearly dividend now sits at approximately $713, a powerful “income on autopilot” milestone.
After two decades, cumulative dividends total $12,815 versus $34,000 invested, nearly a 38% recovery of capital purely from income. Yield on cost reaches 2.07%.
At year 25, the income engine takes over. The portfolio’s annual dividend of $675 is greater than total contributions to date ($40,000), and cumulative dividends exceed $16,307.
By year 30, the DRIP snowball is in full force. Yearly income reaches $634, cumulative dividends total $19,613, and the DRIP portfolio value stands at $369,636, compared with $303,630 if dividends weren’t reinvested.
How we estimate these numbers
We use the latest calculator inputs for CNS, price $65.94, dividend per period $0.62 (4×/year), along with historic growth assumptions: price growth 8.75% and dividend growth -1.89% annually.
We simulate month by month for 30 years. Every month, a $100 contribution is added and converted to shares at that month’s price. Dividends are paid roughly evenly across the year based on the dividend frequency; in the DRIP path, each payout immediately buys additional shares at the then-current price. In the No‑DRIP path, dividends accrue as cash. Prices grow using a monthly rate derived from the annual price growth. Dividends per share increase once per year at the annual dividend growth rate.
This model isn’t investment advice; it’s a simple, transparent framework that illustrates how reinvesting dividends can accelerate both income and total return over time.
Projected Future Returns & Dividends for CNS
Based on past 10-year performance, here are CNS growth metrics:
Using CNS CAGR metrics, we can estimate that your initial $10,000 investment, over the next 10 years, should grow as follows:
CNS (DRIP) | CNS (No DRIP) | |
---|---|---|
Current Price | $65.94 | $65.94 |
Start Shares | 151.65 | 151.65 |
Start Value | $10,000 | $10,000 |
After 10 years: | ||
Final Share Count | 196.20 | 151.65 |
Dividends Payment | $3.08 | $3.08 |
Annual Dividends | $594 | $468 |
Yield on cost | 5.94% | 4.68% |
Share Price | $165.29 | $165.29 |
Total Dividends | $4,878 | $4,249 |
Final Value | $32,429 | $29,315 |
Estimated Future Value + Dividends – CNS
Dividend History: Payments & Yield
Shows quarterly dividend payments with trailing yield and a 5-year rolling average overlay. Use the range pills to switch the visible period.
Dividend Growth
Lifetime quarterly dividend amounts, with range controls for 1Y/2Y/5Y/10Y. Useful to visualize the cadence and pace of dividend increases over time.
Dividend Payments & Yield
Quarterly dividends with TTM yield and a 5‑year rolling average overlay. Helps compare current yield versus recent history across different ranges.
CNS Dividend History
Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
---|---|---|---|---|---|
08/11/2025 | 08/11/2025 | $0.620 | 3.34% | 3.38% | $73.35 |
05/12/2025 | 05/12/2025 | $0.620 | 2.92% | 2.99% | $82.87 |
03/03/2025 | 03/03/2025 | $0.620 | 2.79% | 2.90% | $85.60 |
11/18/2024 | 11/18/2024 | $0.590 | 2.36% | 2.36% | $99.89 |
08/12/2024 | 08/12/2024 | $0.590 | 2.85% | 2.88% | $82.02 |
05/10/2024 | 05/10/2024 | $0.590 | 3.28% | 3.34% | $70.72 |
03/01/2024 | 03/01/2024 | $0.590 | 3.15% | 3.23% | $73.05 |
11/10/2023 | 11/10/2023 | $0.570 | 4.32% | 4.32% | $52.82 |
08/11/2023 | 08/11/2023 | $0.570 | 3.43% | 3.46% | $65.98 |
05/12/2023 | 05/12/2023 | $0.570 | 4.13% | 4.20% | $54.30 |
03/03/2023 | 03/03/2023 | $0.570 | 3.10% | 3.18% | $71.69 |
11/10/2022 | 11/10/2022 | $0.550 | 3.41% | 3.41% | $64.45 |
08/12/2022 | 08/12/2022 | $0.550 | 4.31% | 2.83% | $77.66 |
05/13/2022 | 05/13/2022 | $0.550 | 4.46% | 3.02% | $72.87 |
03/04/2022 | 03/04/2022 | $0.550 | 4.04% | 2.82% | $78.01 |
11/12/2021 | 11/12/2021 | $1.70 | 3.06% | 6.82% | $99.75 |
08/13/2021 | 08/13/2021 | $0.450 | 3.11% | 2.04% | $88.17 |
05/14/2021 | 05/14/2021 | $0.450 | 3.67% | 2.46% | $73.08 |
03/05/2021 | 03/05/2021 | $0.450 | 3.98% | 2.73% | $65.89 |
11/13/2020 | 11/13/2020 | $1.39 | 4.02% | 8.74% | $63.61 |
08/14/2020 | 08/14/2020 | $0.390 | 5.71% | 2.52% | $61.87 |
05/15/2020 | 05/15/2020 | $0.390 | 5.88% | 2.62% | $59.50 |
02/28/2020 | 02/28/2020 | $0.390 | 5.54% | 2.49% | $62.65 |
11/15/2019 | 11/15/2019 | $2.36 | 5.25% | 14.41% | $65.49 |
08/09/2019 | 08/09/2019 | $0.360 | 7.38% | 2.72% | $52.96 |
05/10/2019 | 05/10/2019 | $0.360 | 7.66% | 2.84% | $50.63 |
03/01/2019 | 03/01/2019 | $0.360 | 9.19% | 3.44% | $41.88 |
11/16/2018 | 11/16/2018 | $2.83 | 10.66% | 31.58% | $35.84 |
08/15/2018 | 08/15/2018 | $0.330 | 5.43% | 3.16% | $41.78 |
05/30/2018 | 05/30/2018 | $0.330 | 5.64% | 3.35% | $39.38 |
03/07/2018 | 03/07/2018 | $0.330 | 5.26% | 3.20% | $41.27 |
11/21/2017 | 11/21/2017 | $1.28 | 4.74% | 11.45% | $44.73 |
08/30/2017 | 08/30/2017 | $0.280 | 4.28% | 2.99% | $37.41 |
05/30/2017 | 05/30/2017 | $0.280 | 4.05% | 2.87% | $39.00 |
03/07/2017 | 03/07/2017 | $0.280 | 4.16% | 2.99% | $37.51 |
11/21/2016 | 11/21/2016 | $0.760 | 4.40% | 8.68% | $35.04 |
08/30/2016 | 08/30/2016 | $0.260 | 3.59% | 2.44% | $42.59 |
05/31/2016 | 05/31/2016 | $0.260 | 3.94% | 2.70% | $38.59 |
03/07/2016 | 03/07/2016 | $0.260 | 4.47% | 3.08% | $33.80 |
11/23/2015 | 11/23/2015 | $0.750 | 4.85% | 9.69% | $30.96 |
09/01/2015 | 09/01/2015 | $0.250 | 6.99% | 3.55% | $28.19 |
05/29/2015 | 05/29/2015 | $0.250 | 5.17% | 2.67% | $37.50 |
03/11/2015 | 03/11/2015 | $0.250 | 4.69% | 2.45% | $40.75 |
11/25/2014 | 11/25/2014 | $1.22 | 4.31% | 11.17% | $43.67 |
09/03/2014 | 09/03/2014 | $0.220 | 4.24% | 2.01% | $43.89 |
05/30/2014 | 05/30/2014 | $0.220 | 4.54% | 2.17% | $40.49 |
03/26/2014 | 03/26/2014 | $0.220 | 4.57% | 2.21% | $39.82 |
11/27/2013 | 11/27/2013 | $1.20 | 4.50% | 12.01% | $39.96 |
09/04/2013 | 09/04/2013 | $0.200 | 7.07% | 2.48% | $32.26 |
05/30/2013 | 05/30/2013 | $0.200 | 5.83% | 2.06% | $38.75 |
03/25/2013 | 03/25/2013 | $0.200 | 6.42% | 2.29% | $34.87 |
11/28/2012 | 11/28/2012 | $1.68 | 7.82% | 23.66% | $28.40 |
09/05/2012 | 09/05/2012 | $0.180 | 2.05% | 2.14% | $33.63 |
05/31/2012 | 05/31/2012 | $0.180 | 5.13% | 2.23% | $32.35 |
03/27/2012 | 03/27/2012 | $0.180 | 5.25% | 2.32% | $31.06 |
12/05/2011 | 12/05/2011 | $0.150 | 5.58% | 2.09% | $28.68 |
09/02/2011 | 09/02/2011 | $1.15 | 4.47% | 13.26% | $34.70 |
06/01/2011 | 06/01/2011 | $0.150 | 8.58% | 2.06% | $29.14 |
03/29/2011 | 03/29/2011 | $0.150 | 8.49% | 2.08% | $28.87 |
12/02/2010 | 12/02/2010 | $0.100 | 8.91% | 1.48% | $26.94 |
09/02/2010 | 09/02/2010 | $2.10 | 11.70% | 41.83% | $20.08 |
06/02/2010 | 06/02/2010 | $0.100 | 1.27% | 1.70% | $23.54 |
03/29/2010 | 03/29/2010 | $0.100 | 1.00% | 1.60% | $24.97 |
12/02/2009 | 12/02/2009 | $0.050 | 1.04% | 1.04% | $19.23 |
09/02/2009 | 09/02/2009 | $0.050 | 1.32% | 1.05% | $19.01 |
06/02/2009 | 06/02/2009 | $0.050 | 2.52% | 1.20% | $16.70 |
03/27/2009 | 03/27/2009 | $0.050 | 4.86% | 1.65% | $12.13 |
12/03/2008 | 12/03/2008 | $0.100 | 5.88% | 3.10% | $12.92 |
09/03/2008 | 09/03/2008 | $0.220 | 2.94% | 3.01% | $29.21 |
06/02/2008 | 06/02/2008 | $0.220 | 2.83% | 2.89% | $30.44 |
03/07/2008 | 03/07/2008 | $0.220 | 3.49% | 3.65% | $24.10 |
12/03/2007 | 12/03/2007 | $0.200 | 2.89% | 2.81% | $28.44 |
11/20/2007 | 11/20/2007 | $0.222 | 2.87% | 3.10% | $28.60 |
08/31/2007 | 08/31/2007 | $0.200 | 2.20% | 2.41% | $33.23 |
05/31/2007 | 05/31/2007 | $0.200 | 1.27% | 1.54% | $51.99 |
03/30/2007 | 03/30/2007 | $0.200 | 1.32% | 1.86% | $43.08 |
12/29/2006 | 12/29/2006 | $0.130 | 1.19% | 1.29% | $40.17 |
09/28/2006 | 09/28/2006 | $0.130 | 1.44% | 1.62% | $32.01 |
06/27/2006 | 06/27/2006 | $0.110 | 1.88% | 1.92% | $22.87 |
03/27/2006 | 03/27/2006 | $0.110 | 1.82% | 1.82% | $24.22 |
12/27/2005 | 12/27/2005 | $0.110 | 2.43% | 2.38% | $18.51 |
10/12/2005 | 10/12/2005 | $0.100 | 2.34% | 2.12% | $18.84 |
06/13/2005 | 06/13/2005 | $0.120 | 2.35% | 2.56% | $18.74 |
05/11/2005 | 05/11/2005 | $0.120 | 2.49% | 2.85% | $16.85 |
03/24/2005 | 03/24/2005 | $0.100 | 1.88% | 2.50% | $15.97 |
12/27/2004 | 12/27/2004 | $0.100 | 1.31% | 2.63% | $15.22 |
09/23/2004 | 09/23/2004 | $0.100 | 0.63% | 2.51% | $15.92 |
Dividend Payout Ratio
Tracks the percentage of earnings paid out as dividends each quarter. Lower and stable ratios often indicate safer, more sustainable payouts.
Dividend to Free Cash Flow Ratio
Shows dividends as a percentage of free cash flow. Consistently high values may signal limited reinvestment capacity or potential dividend risk.
Share Price
Historical closing price with range controls. Table view includes quarter‑over‑quarter and year‑over‑year changes for additional context.
Price to Earnings
CNS trades at a 90.3x price-to-earnings ratio. This elevated valuation suggests investors expect strong future growth.
Price to Sales
CNS trades at a 26.6x price-to-sales ratio, providing insight into market valuation relative to revenue generation.
Revenue
CNS generated $0.1B in revenue.
Net Income
CNS reported $0.0B in net income. Net income has declined by 21% over the period.
Revenue vs Net Income
CNS generated $0.1B in revenue with net income of $0.0B, representing a 29.4% net profit margin.
Gross Profit
CNS achieved $0.1B in gross profit, showing revenue after direct production costs.
Operating Income
CNS generated $0.0B in operating income, representing profit from core business operations.
EBITDA
CNS generated $0.1B in EBITDA, measuring operational profitability before interest, taxes, depreciation, and amortization.
Operating Cash Flow
CNS generated $0.0B in operating cash flow, demonstrating the company’s ability to convert earnings into cash.
Free Cash Flow
CNS generated $0.0B in free cash flow. Free cash flow has decreased by 23% over the period.
Free Cash Flow / Share
CNS generates $0.84 in free cash flow per share. FCF per share has declined by 23% over the period.
Earnings Per Share (EPS)
CNS reported $0.82 in earnings per share. EPS has declined by 21% over the period.
Return on Equity (ROE)
CNS delivered a 24.5% return on equity, indicating how effectively the company generates returns for shareholders.
Return on Assets (ROA)
CNS achieved a 14.7% return on assets, measuring how efficiently the company uses its assets to generate profit.
Net Profit Margin
CNS maintains a 29.4% net profit margin, showing the percentage of revenue retained as profit after all expenses.
Gross Profit Margin
CNS operates with a 76.7% gross profit margin, reflecting pricing power and cost efficiency in core operations.
Cash & Debt
CNS holds $0.0B in cash against $0.0B in debt, resulting in a net cash position of $0.0B.
Shares Outstanding
CNS has 0.1B shares outstanding.
Stock-Based Comp
CNS reported $0.0B in stock-based compensation.
FCF vs Stock Based Comp
CNS generated $0.0B in free cash flow while spending $0.0B on stock-based compensation, representing 8% of FCF.
FCF vs FCF / Share
CNS reported $0.0B in free cash flow, translating to $0.84 per share.
Revenue: Actual + Estimates
This chart tracks CNS revenue: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.
EPS: Actual + Estimates
This chart tracks CNS eps: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.
Net Income: Actual + Estimates
This chart tracks CNS net income: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.
EBITDA: Actual + Estimates
This chart tracks CNS ebitda: actual + estimates metrics over time, providing insights into the company’s financial performance and trends.